Evommune, Inc. (EVMN)
NYSE · Healthcare
Evommune, Inc. Cash Flow 2024–2025
| Dec 2025 | Dec 2024 | |
|---|---|---|
| Operating Activities | ||
| Operating Cash Flow | -76.4M | -58.2M |
| Depreciation & Amort. | 600,000 | 500,000 |
| Investing Activities | ||
| Capital Expenditure | 235,000 | 88,000 |
| Free Cash Flow | -76.7M | -58.3M |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Buybacks | — | — |
Evommune, Inc. Cash Flow — FAQ
Evommune, Inc. (EVMN) cash flow over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EVMN's cash flow history?
The chart and table above show Evommune, Inc.'s cash flow by year and by quarter, including the growth rate.